Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

SKBI 4.14 -0.04 (-0.96%)
price chart
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
NEW YORK ( TheStreet) -- Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI) has been upgraded by TheStreet Ratings from sell to hold.
Related articles »  
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Skystar Bio-Pharmaceutical Company: Skystar Bio-Pharmaceutical Reports ...  The Wall Street Transcript
Related articles »  
Update: Skystar Bio-Pharmaceutical Company Q3 Earnings - Key Developments ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) reported double-digit increases for both revenue and net income for Q3. Revenue increased 14.8% to $18.4 million, while net income increased 32% to $4.9 million or $0.57 per fully diluted share.
Related articles »  
Skystar Bio-Pharmaceutical Company major shareholder Acquires $469753 in ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 103,016 shares of the stock on the open market in a transaction that occurred on Wednesday, December 10th.
Skystar Bio - Pharmaceutical Company (SKBI) Q2 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Second Quarter Fiscal 2014 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Skystar Bio-Pharmaceutical to File Financial Results for Second Quarter of ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical Company major shareholder Purchases $469753 in ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 103,016 shares of Skystar Bio-Pharmaceutical Company stock on the open market in a transaction dated ...
Market Alert: Skystar Bio Pharmaceutical Company (NASDAQ:SKBI), Cytori ...  Property Mentor
Related articles »  
Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of ...
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file its financial results for the third quarter of ...
Skystar Bio-Pharmaceutical Reports Third Quarter Fiscal Year 2014 Financial ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical Company major shareholder John M. Gregory ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory acquired 103,016 shares of the stock on the open market in a transaction dated Wednesday, December 10th.
Related articles »  
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results ...
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results - Earnings Call Transcript. May. 16, 2014 10:12 AM ET | About: Skystar Bio - Pharmaceutical Company (SKBI) by: SA Transcripts. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI).
Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical Provides Update to Its Patent Portfolio
Skystar is currently waiting for the SIPO office to issue the Company physical patent certificates for the two products.
Related articles »